The decision on when to start drugs for the treatment of elevated blood pressure should be determined by an individual's absolute risk of having an adverse cardiovascular event. The choice of drug depends on its safety and effectiveness and its indications and contraindications for individual patients. most patients will require two or more drugs to reach their target blood pressure. The main classes of antihypertensive drugs are equally effective at reducing blood pressure, but beta blockers are no longer recommended as first-line treatment for most patients.
Introduction
All patients with elevated blood pressure should be encouraged to have a healthy lifestyle. 1 Although there are benefits from weight loss, salt and alcohol reduction and exercise, these lifestyle changes may be insufficient to control a patient's blood pressure. This leaves them at risk of coronary heart disease, stroke and renal failure. If the high blood pressure is confirmed by accurate measurements on several occasions, drug treatment should be considered.
Who should receive drug therapy?
Drug treatment for elevated blood pressure should not be based solely on accurate blood pressure readings. It should also consider an individual's absolute cardiovascular risktheir risk of having a stroke or myocardial infarction over a specified period of time, usually five years. 2 An absolute risk calculator can be used to identify who is most likely to benefit from treatment. 3 The previous underestimation of risk in Aboriginal and Torres Strait Islander people by such calculators has been addressed in the recently published Australian risk calculator. [4] [5] [6] Immediate treatment to lower blood pressure is recommended for patients with confirmed hypertension (multiple measures on at least two separate occasions):
n systolic blood pressure 180 mmHg or greater n diastolic blood pressure 110 mmHg or greater n systolic blood pressure 160 mmHg or greater and diastolic blood pressure 70 mmHg or less.
Patients with associated conditions (for example, stroke or myocardial infarction) or evidence of end-organ damage (for example, microalbuminuria, left ventricular hypertrophy) also need urgent treatment (Fig. 1 ).
Starting drug therapy
Once the decision has been made to start drug therapy, the choice of antihypertensive drug should be based on the patient's age and the presence of associated clinical conditions or end-organ damage. The presence of other diseases may favour or limit the use of particular drug classes and there may be potential interactions with other drugs (Table 1) .
Cost and the ease of adhering to treatment should also be Attaining and maintaining the target blood pressure may be assisted by:
n choice of long-acting drugs to provide once-daily administration n regular assessment and encouragement of drug adherence n treating the patient as a partner in management decisions and involving the patient's family when appropriate n providing specific written instructions and patient education materials n discussing the use of dose administration aids (e.g. dosette boxes, blister packs) and home medicines review n use of self-measurement of blood pressure for monitoring, if appropriate n evaluating the social and economic barriers that may affect medication supply and storage n using effective combinations (Table 2 ) when more than one drug is required.
Combination therapy
Approximately 60% of patients with elevated blood pressure will not achieve their blood pressure targets with monotherapy. Most patients will require a combination of two or more drugs to achieve adequate blood pressure control.
There are several effective combinations ( 
Resistant blood pressure
Failure to control blood pressure can be due to a wide range of prescriber, patient, healthcare system and drug related factors.
If blood pressure remains above the target despite maximal doses of at least two appropriate drugs after a reasonable period, consider the following potential explanations:
n non-adherence to drug therapy and lifestyle modifications n secondary hypertension (e.g. sleep apnoea, chronic kidney disease)
n use of drugs that may increase blood pressure (e.g. non-steroidal anti-inflammatory drugs, prednisolone)
n alcohol or recreational drug use n high salt intake (particularly in patients taking ACE inhibitors or angiotensin II receptor antagonists)
n 'white coat' hypertension n blood pressure measurement artefact n volume overload (especially with chronic kidney disease).
Drug treatment in older people
In the elderly, isolated elevated systolic blood pressure is more prevalent due to large vessel stiffness associated with ageing.
Calcium channel blocker-or diuretic-based drug treatment is recommended.
In the very elderly, the recommended blood pressure targets may be difficult to achieve due to comorbidity, reduced physiological function and polypharmacy. However, the elderly are most at risk of adverse cardiovascular events and trials have shown that drug therapy is just as effective in advanced age. The HYpertension in the Very Elderly Trial (HYVET) studied patients aged 80 years or more (mean age 83.6 years).
It showed a 39% relative reduction in the rate of death from stroke, a 21% reduction in the rate of death from any cause, a 23% reduction in the rate of death from cardiovascular causes and a 64% reduction in the rate of heart failure for those on active treatment versus placebo. Fewer serious adverse events were reported in the active treatment group so concerns about causing more harm than good are allayed. 11
Conclusion
Drug therapy is warranted in individuals with a high risk of adverse cardiovascular events. It does not obviate the need for behavioural modification. All classes of antihypertensive drugs have similar efficacy, but specific recommendations are made according to the patient's characteristics. Whichever drug is started, it is important to treat until the target blood pressure is reached. Usually more than one drug is required to reach the target.
